EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Formulation and Design of Biopharmaceuticals for the Treatment of Autoimmune Diseases

Dr. Nida Imran

American Journal of Pharmaceutics · 2025-02-28 · 6 (1) · 11-20

DOI: 10.71465/ajph2735 ↗

At a glance

Journal article in American Journal of Pharmaceutics, published online on 2025-02-28. Written by Dr. Nida Imran. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Autoimmune diseases represent a group of conditions where the immune system mistakenly attacks the body’s own cells. Biopharmaceuticals have emerged as a promising class of therapeutic agents for treating these diseases by targeting specific components of the immune system. This article discusses the formulation and design of biopharmaceuticals, including monoclonal antibodies, cytokine inhibitors, and other biologics, for the treatment of autoimmune disorders. The mechanisms of action, challenges in formulation, and regulatory considerations are explored. Additionally, the article highlights the advancements in personalized medicine, which aim to optimize biopharmaceutical therapies based on individual patient profiles.

Cite

APA

Imran, D. N. (2025). Formulation and Design of Biopharmaceuticals for the Treatment of Autoimmune Diseases. American Journal of Pharmaceutics, 6(1), 11-20. https://doi.org/10.71465/ajph2735

Vancouver

Imran DN. Formulation and Design of Biopharmaceuticals for the Treatment of Autoimmune Diseases. American Journal of Pharmaceutics. 2025;6(1):11-20. doi:10.71465/ajph2735

BibTeX
@article{Imran2025,
  author = {Imran, Dr. Nida},
  title = {Formulation and Design of Biopharmaceuticals for the Treatment of Autoimmune Diseases},
  journal = {American Journal of Pharmaceutics},
  year = {2025},
  volume = {6},
  number = {1},
  pages = {11--20},
  doi = {10.71465/ajph2735}
}
Start for free →